News | April 24, 2026
Rossari Biotech reviews capex, delays Unitop and Tristar expansion rollout
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
This facility underwent an inspection from 15th to 19th July 2024 and has been classified as Voluntary Action Indicated
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
Subscribe To Our Newsletter & Stay Updated
